Therapeutics

An international research group, led by Arizona State University professor Qiang "Shawn" Chen, has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus and other pathogens.
| 3 min read

Developing a new drug takes enormous amounts of time, money and skill, but the bar is even higher for a promising stem-cell therapy. Many types of cells derived from these ultra-flexible parent cells are moving toward the market, but the very quality that makes stem cells so valuable also makes them a difficult source of therapeutics.
| 3 min read

Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College announced Oct. 1 that they have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) and have partnered with Takeda Pharmaceutical Company, Ltd. (TSE:4502).
| 5 min read









